LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $350,000 | +9.4% | 82,600 | 0.0% | 0.00% | – |
| Q4 2020 | $320,000 | -3.9% | 82,600 | 0.0% | 0.00% | – |
| Q3 2020 | $333,000 | -5.4% | 82,600 | 0.0% | 0.00% | – |
| Q2 2020 | $352,000 | +5.7% | 82,600 | +4.0% | 0.00% | – |
| Q1 2020 | $333,000 | +6.7% | 79,400 | 0.0% | 0.00% | – |
| Q4 2019 | $312,000 | -55.4% | 79,400 | 0.0% | 0.00% | – |
| Q3 2019 | $699,000 | -8.7% | 79,400 | -4.1% | 0.00% | – |
| Q2 2019 | $766,000 | +266.5% | 82,800 | +154.8% | 0.00% | – |
| Q1 2019 | $209,000 | -80.6% | 32,500 | -71.6% | 0.00% | -100.0% |
| Q4 2018 | $1,079,000 | +140.3% | 114,448 | +413.2% | 0.00% | – |
| Q3 2018 | $449,000 | -36.4% | 22,300 | -7.9% | 0.00% | – |
| Q2 2018 | $706,000 | -78.8% | 24,200 | -78.4% | 0.00% | -100.0% |
| Q1 2018 | $3,338,000 | +506.9% | 112,100 | +555.6% | 0.00% | – |
| Q4 2017 | $550,000 | -53.6% | 17,100 | -49.9% | 0.00% | -100.0% |
| Q3 2017 | $1,186,000 | +133.0% | 34,100 | +99.4% | 0.00% | – |
| Q2 2017 | $509,000 | +34.3% | 17,100 | +34.6% | 0.00% | – |
| Q1 2017 | $379,000 | +70.0% | 12,700 | 0.0% | 0.00% | – |
| Q4 2016 | $223,000 | -26.2% | 12,700 | 0.0% | 0.00% | – |
| Q3 2016 | $302,000 | +48.8% | 12,700 | 0.0% | 0.00% | – |
| Q2 2016 | $203,000 | -1.0% | 12,700 | +67.1% | 0.00% | – |
| Q4 2015 | $205,000 | – | 7,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |